Literature DB >> 9755853

Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B.

M Bond1, R P Fabunmi, A H Baker, A C Newby.   

Abstract

Matrix metalloproteinase (MMPs) enzymes are implicated in matrix remodelling during proliferative inflammatory processes including wound healing. We report here synergistic upregulation of MMP-9 protein and mRNA by platelet-derived growth factor (PDGF) or basic fibroblast growth factor (bFGF) in combination with interleukin-1alpha (IL-1alpha) or tumour necrosis factor-alpha (TNF-alpha) in primary rabbit and human dermal fibroblasts. The synergistic interaction between growth factors and cytokines implies that basement membrane remodelling is maximal physiologically when both are present together. The signalling pathways mediating this synergistic regulation are not understood, although analysis of the MMP-9 promoter has identified an essential proximal AP-1 element and an upstream nuclear factor kappa-B (NF-kappaB) site. Using electromobility shift assays, binding to the AP-1 site was only slightly increased by growth factors and cytokines. NF-kappaB binding was rapidly induced by IL-1alpha or TNF-alpha but was neither induced nor potentiated by bFGF or PDGF. Neither AP-1 nor NF-kappaB was therefore sufficient on its own for synergistic regulation. Using a recently developed adenovirus that overexpresses the inhibitory subunit, IkappaB alpha, we demonstrated an absolute requirement for NF-kappaB in upregulation of MMP-9. Activation of NF-kappaB binding by inflammatory cytokines was therefore necessary but not sufficient for synergistic upregulation of MMP-9.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755853     DOI: 10.1016/s0014-5793(98)01034-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  128 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Escherichia coli cytotoxic necrotizing factor 1 inhibits intestinal epithelial wound healing in vitro after mechanical injury.

Authors:  Patrick Brest; Laurent Turchi; Gaëlle Le'Negrate; Frédérick Berto; Chimène Moreilhon; Bernard Mari; Gilles Ponzio; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation.

Authors:  Joshua D Brooks; Erik S Musiek; Tyler R Koestner; Jeannette N Stankowski; Jocelyn R Howard; Enrico M Brunoldi; Alessio Porta; Giuseppe Zanoni; Giovanni Vidari; Jason D Morrow; Ginger L Milne; BethAnn McLaughlin
Journal:  J Neurochem       Date:  2011-09-23       Impact factor: 5.372

4.  Uncoupling angiogenesis and inflammation in peripheral artery disease with therapeutic peptide-loaded microgels.

Authors:  Angela L Zachman; Xintong Wang; Jason M Tucker-Schwartz; Sean T Fitzpatrick; Sue H Lee; Scott A Guelcher; Melissa C Skala; Hak-Joon Sung
Journal:  Biomaterials       Date:  2014-08-22       Impact factor: 12.479

Review 5.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

Review 6.  Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.

Authors:  Robert Vander Broek; Grace E Snow; Zhong Chen; Carter Van Waes
Journal:  Oral Oncol       Date:  2013-10-28       Impact factor: 5.337

Review 7.  TWEAK as a target for therapy in systemic lupus erythematosus.

Authors:  Rui-Xue Leng; Hai-Feng Pan; Wei-Zi Qin; Chao Wang; Li-Li Chen; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-04-01       Impact factor: 2.316

8.  High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.

Authors:  Rosane M B Teles; Rose B Teles; Thais P Amadeu; Danielle F Moura; Leila Mendonça-Lima; Helen Ferreira; Italo M C F Santos; José A C Nery; Euzenir N Sarno; Elizabeth P Sampaio
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

Review 9.  Matrix metalloproteinases: changing roles in tumor progression and metastasis.

Authors:  Laurie A Shuman Moss; Sandra Jensen-Taubman; William G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2012-10-12       Impact factor: 4.307

10.  Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Donald M Lamkin; Nicholas B Jennings; Jesusa M G Arevalo; Frank Penedo; Koen DeGeest; Robert R Langley; Joseph A Lucci; Steve W Cole; David M Lubaroff; Anil K Sood
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.